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Introduction
Productive infection of nondividing cells by the human 
and simian immunodeficiency viruses (HIV and SIV, re-
spectively) requires active nuclear transport of the viral 
DNA across the host cell nuclear membrane prior to vi-
ral dsDNA integration into the host genome. This task is 
accomplished through the viral preintegration complex 
(PIC), a nucleoprotein complex composed of cellular and 
viral components (reviewed in Fouchier and Malim 1999). 
The viral components include the dsDNA, reverse tran-
scriptase, matrix, nucleocapsid, integrase, and Vpr (HIV-
1) or Vpx (HIV-2/SIV) proteins (Bukrinsky et al. 1993b, 
Farnet and Haseltine 1991, Hansen and Bushman 1997, 
Heinzinger et al. 1994, and Miller et al. 1997). The matrix, 
integrase, Vpr, and Vpx proteins have each been identi-
fied as having karyophilic properties (Bukrinsky et al. 
1993a, Gallay et al. 1997, Heinzinger et al. 1994, and Pan-
cio et al. 2000). Although each of these proteins has been 
demonstrated to be a crucial regulator of nuclear import 
of the PIC, it remains unclear as to the exact contribution 
each protein plays. In addition, the central DNA flap has 
also been shown to be an important signal for nuclear en-
try of the PIC (Zennou et al. 2000).
There is significant sequence homology among the 
Vpr and Vpx proteins (Tristem et al. 1990 and Tristem et 
al. 1998). Both are of similar size (14–17 kDa), are pack-
aged in virions, and possess similar functions (Fletcher et 
al. 1996). The Vpr protein of HIV-1 has been extensively 
studied and demonstrated to possess at least two discrete 
functions. Early in virus replication, Vpr mediates infec-
tion of nondividing cells by directing nuclear import of 
viral PICs (Popov et al. 1998). Vpr contains two discrete 
NLSs that directly target to the nuclear pore complex 
(NPC) and facilitate entry into the nucleus (Jenkins et al. 
1998). It has also been proposed that Vpr-induced herni-
ation of the nuclear envelope structure may facilitate PIC 
import (De Noronha et al. 2001). Vpr has also been dem-
onstrated to cause G2 cell-cycle arrest of proliferating cells 
(Goh et al. 1994). This effect may contribute to increased 
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Abstract
The Vpx protein of human immunodeficiency virus type 2 (HIV-2) is a viral accessory protein related to, but distinct from, the 
Vpr protein of HIV-1. Vpx is packaged into virions and, as a component of the viral preintegration complex (PIC), Vpx is required 
for efficient virus replication in nondividing cells. Therefore, the localization of Vpx in cells is dynamic and dependent upon dis-
crete domains of the protein. Expressed in the absence of other viral proteins, Vpx localizes to the nucleus of cells. However, if ex-
pressed with the Gag protein of HIV-2, Vpx localizes to the plasma membrane of cells. To further understand the regulation of 
Vpx localization, we fused regions of Vpx to β-galactosidase to identify regions of the protein sufficient to mediate nuclear local-
ization. The minimal transferable region of Vpx that conferred nuclear localization in these assays was aa 65 to 72. Alanine sub-
stitution of K68 and R70 in a GFP-Vpx construct abolished nuclear localization, suggesting that the basic residues in this region are 
important for nuclear import. Analysis of the membrane transport of several GFP-Vpx alanine mutants demonstrated that while 
separable, the domains of Vpx required for nuclear localization are not distinct from the domains required for membrane trans-
port. The results of heterokaryon shuttling assays indicated that Vpx is not a shuttling protein; however, HIV-2 Vpr did shuttle 
similar to HIV-1 Vpr.
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virus production since viral transcription is most active 
during this phase of the cell cycle (Goh et al. 1994). Inter-
estingly, two nonarresting mutants of Vpr failed to alter 
nuclear membrane morphology, suggesting that nuclear 
membrane disruption may contribute to G2 cell-cycle ar-
rest (De Noronha et al. 2001). HIV-1 Vpr has also been 
demonstrated to be a shuttling protein capable of nuclear 
import and export (Sherman et al. 2001). While the role of 
shuttling on Vpr function has not been elucidated, it has 
been shown to be dispensible for packaging of Vpr into 
virions (Jenkins et al. 2001). Mutation of the nuclear ex-
port signal of Vpr abolished Vpr-mediated nuclear mem-
brane herniation (De Noronha et al. 2001). Together, these 
results suggest that Vpr shuttling may be important for 
Vpr-mediated cell-cycle arrest.
Unlike HIV-1, HIV-2 contains both the vpr and the vpx 
genes, each with discrete functions (Fletcher et al. 1996). 
HIV-2 Vpr has been demonstrated to arrest cells in G2, 
but plays no role in nuclear import of the PIC (Fletcher 
et al. 1996). Vpx is a 17-kDa, 112 amino acid (aa) protein 
that is packaged into virions but is not crucial for virion 
morphology. HIV-2 Vpx is necessary for efficient replica-
tion in nondividing cells (Pancio et al. 2000). As a com-
ponent of the HIV-2 PIC, Vpx, similar to HIV-1 Vpr, has 
been shown to be necessary and sufficient for nuclear 
translocation of the PIC, but plays no role in integration 
(Hansen and Bushman 1997). As such, Vpx plays an im-
portant role in the early steps of virus replication. Indeed, 
SIVsm Vpx has been demonstrated to be required for vi-
rus dissemination and pathogenesis in vivo (Hirsch et al. 
1998). This may be due to the nuclear import role of Vpx 
in allowing infection of quiescent cells. The cellular local-
ization of Vpx is dynamic and dependent upon discrete 
domains within the protein. Expressed in the absence of 
other HIV-2 components, Vpx exhibits a predominantly 
nuclear localization, with limited perinuclear localization 
(Mahalingam et al. 2001 and Pancio et al. 2000). However, 
expressed in the presence of HIV-2 Gag, Vpx is observed 
to localize to the plasma membrane (Pancio et al. 2000). 
The interaction of Vpx and Gag facilitates the packaging 
of Vpx during virus assembly. Plasma membrane local-
ization and packaging of Vpx are mediated through the 
interaction of aa 81–86 of Vpx with aa 15–40 of the HIV-2 
p6 protein (Jin et al. 2001 and Selig et al. 1999).
Previous work suggested that the C-terminus of Vpx 
contained an NLS (Pancio et al. 2000). These studies dem-
onstrated that deletion of the 11 C-terminal aa of Vpx 
abolished nuclear localization of a GFP-Vpx fusion, re-
sulted in decreased nuclear import of viral PICs, and de-
creased virus replication in macrophage cultures. These 
studies were confirmed in another article (Mahalingam et 
al. 2001). Using GFP fusion proteins, this study also iden-
tified an NLS in a broad region of Vpx (aa 60–85) (Ma-
halingam et al. 2001). Several mutations in this region, in-
cluding both charged (H82) and hydrophobic residues 
(L74 and L75), abolished nuclear localization. Other C-
terminal mutations were also found to be deleterious to 
Vpx nuclear localization, further suggesting the C-ter-
minus of Vpx (aa 60–112) is required for full nuclear tar-
geting capability. Here we report that aa 65 to 72 is the 
minimal transferable region of Vpx that contains nu-
clear localization properties. Furthermore mutation of ba-
sic residues in this region disrupted nuclear localization 
of a GFP–Vpx fusion, but was not deleterious to mem-
brane transport in the presence of Gag- Pol. These results 
demonstrate that the nuclear localization and membrane 
transport of Vpx are separable. However, other mutations 
C-terminal to this region in Vpx disrupted both nuclear 
localization and membrane transport, indicating that the 
requirements for both functions are not discrete. Defining 
the mechanism of Vpx nuclear import may lead to the de-
velopment of therapeutic interventions at early stages of 
virus replication.
Results
Construction and expression of lacZ–vpx fusions
Published reports conflict as to the exact size limit (40–60 
kDa) of proteins capable of passive diffusion between the 
nucleus and cytoplasm of cells. Therefore, to identify the 
domain(s) of Vpx that facilitates nuclear localization, we 
constructed a series of lacZ–vpx fusions. The use of β-galac-
tosidase (β-gal) as a fusion partner for the Vpx fragments 
resulted in proteins greater than 100 kDa in size, which 
Figure 1. Amino acid sequence of HIV-2 ROD Vpx and expres-
sion of β-gal–Vpx fusion proteins. (A) Amino acid sequence of 
HIV-2 ROD Vpx. (B) Western blot of lysates from 293T cells 
transiently transfected with indicated lacZ–vpx fusions (num-
bers indicate aa of Vpx present in fusion). Fusion proteins 
were detected using a monoclonal anti-β-gal antibody fol-
lowed by an alkaline phosphatase conjugated anti-mouse sec-
ondary antibody. Antibody binding was detected using West-
ern blue (Promega) colorimetric substrate. 
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would require active transport to move into and out of 
the nucleus. Full-length and smaller regions of vpx (Fig-
ure 1A) were inserted at the 3′ end of the lacZ gene in a 
eukaryotic expression vector pCR3.1 (Invitrogen). The 
nuclear localization signal (NLS) of the large T antigen of 
SV40 was used as a positive control. Expression of these 
β-gal–Vpx fusion proteins was detected by Western blot 
of transiently transfected 293T cells using an anti-β-gal 
monoclonal antibody (Promega) (Figure 1B). All proteins 
were of the predicted size.
Amino acids 61 to 75 of Vpx facilitate nuclear localization of 
heterologous proteins
The localization of the β-gal fusions was first assessed 
by immunofluorescence microscopy of transiently trans-
fected HeLa cells using an anti-β-gal antibody (Promega), 
followed by a FITC-conjugated secondary antibody (Fig-
ure 2). β-Gal alone localized exclusively to the cytoplasm 
of cells and, as expected, the lacZ-NLS positive control 
was observed exclusively in the nuclei of transfected cells. 
The fusion containing full-length Vpx was also observed 
to have a predominantly nuclear phenotype. Analysis of 
the β-gal fusion containing partial fragments of Vpx (β-
gal:61–112, β-gal:61–79) indicated that amino acids 61–79 
conferred a predominantly nuclear phenotype similar to 
full-length Vpx. However, fusion proteins lacking this re-
gion (e.g., β-gal:1–60, β-gal:86–112) demonstrated diffuse 
cellular staining or only cytoplasmic localization. These 
findings are consistent with a previous report by Ma-
halingam et al.. demonstrating that aa 60–85 contained a 
transferable NLS (Mahalingam et al. 2001). Further dissec-
tion of this region with overlapping Vpx regions (aa 61–
72, 65–75, 69–79) demonstrated that both aa 61–72 and aa 
65–75 conferred a predominantly nuclear phenotype, sug-
gesting that the overlapping region (residues 65–72) con-
tained an NLS.
To confirm the immunofluorescence data, cells tran-
siently transfected with the lacZ–vpx expression plasmids 
were fractionated and β-gal assays were performed to de-
termine the level of activity in the nuclear and cytoplas-
mic compartments. Separation of the cytoplasmic and nu-
clear extracts was confirmed by the lack of detection of 
the cytoplasmic protein lactate dehydrogenase (LDH) in 
the nuclear fraction (data not shown). The β-gal results 
were expressed as a ratio of the nuclear to cytoplasmic 
(N/C) activity. Therefore, a ratio > 1.0 would indicate a 
predominantly nuclear protein. Indeed, the N/C ratio of 
the β-gal-NLS positive control was >7.0. The N/C ratio 
for β-gal alone was ~1.0 (Figure 3), which is defined as cy-
toplasmic in this assay. Indeed, those fusion proteins ob-
served to be cytoplasmic by immunofluorescence all ex-
hibited a N/C ratio of 0.84–1.43. In contrast, all fusion 
proteins that contained Vpx amino acid residues 65–72 ex-
Figure 2. Subcellular localization of β-gal–Vpx fusion proteins. β-gal–Vpx fusion proteins were detected in transiently 
transfected HeLa cells by indirect immunofluorescence as described under Materials and methods. The regions of Vpx 
contained in each fusion are given. Nuclei were visualized by staining with DAPI and are shown in panels to the right 
of the immunofluorescence images. 
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hibited a N/C ratio > 2.0, confirming the results observed 
with the immunofluorescence. However, the ratios of the 
fusions that contained smaller fragments of Vpx were re-
duced in comparison to the full-length β-gal–Vpx fusion, 
suggesting other regions of Vpx may enhance nuclear lo-
calization or retention.
Alanine scanning mutagenesis of Vpx nuclear localization
Amino acids 65 to 72 are highly conserved among HIV-
2 and SIV strains. This region contains several tyrosine 
residues and two basic residues (K68 and R70). To further 
analyze the nuclear targeting potential of this region, we 
constructed several pEGFP-Vpx clones with alanine sub-
stitutions in this region and assessed their cellular local-
ization in transient transfection assays (Figure 4). Alanine 
substitution of the two serines at positions 63 and 65 did 
not impair nuclear targeting of the fusion protein. How-
ever, alanine substitution of the two basic residues alone 
(A68,70) or together with the tyrosine residues (A66,68–
71) abolished nuclear targeting of the fusion proteins, in-
dicating that these two residues are critical for nuclear 
targeting of the fusion protein. These results further sug-
gest that aa 65–72 of Vpx is an NLS. We had previously 
constructed several alanine-scanning mutants of Vpx in 
the context of a molecular clone (Jin et al. 2001). Two of 
these mutants (A74–80 and A80–86) were cloned into the 
GFP fusion vector and their localization was assessed by 
fluorescence microscopy. Both mutants produced inter-
esting phenotypes. The mutant with alanine substitutions 
of aa 74 to 80 (A74–80) displayed a predominantly cyto-
plasmic phenotype compared to wild-type GFP-Vpx, sug-
gesting this region is also important for nuclear localiza-
tion of Vpx. Another mutant, with alanine substitutions 
of aa 80–86 (A80–86), while able to enter the nucleus of 
cells, appeared to accumulate on the nuclear membrane, 
suggesting a partial defect in nuclear translocation. These 
data are consistent with previous work from our labora-
tory and others that identified numerous mutations C-ter-
minal to aa 65–72 that disrupted nuclear targeting of Vpx 
(Mahalingam et al. 2001 and Pancio et al. 2000).
Membrane transport and subsequent packaging of Vpx 
into virions require an interaction with the p6 region of 
Gag. To assess the membrane transport capability of each 
alanine scanning mutant, we cotransfected each GFP-Vpx 
mutant plasmid with a HIV-2 Gag-Pol plasmid (pTM-
GP2) expressed by the T7-vaccinia expression system. As 
previously described (Pancio et al. 2000), GFP-Vpx was 
observed at the membrane of cells when coexpressed with 
Gag-Pol ( Figure 5, arrows). Alanine substitution of aa 
74–80 and 80–86 had been previously shown to be dele-
terious to Vpx packaging (Jin et al. 2001) and, as expected, 
both mutants failed to demonstrate membrane targeting 
when expressed with Gag-Pol ( Figure 5). The three other 
alanine mutants (A63,65; A66,68–71; A68,70) exhibited 
membrane localization similar to wild-type GFP-Vpx, in-
dicating that alanine substitution in this region was not 
deleterious to targeting of Vpx to the membrane. Further-
more, these results demonstrate that nuclear localization 
and membrane targeting are separable, but not discrete 
since A74–80 is deficient for both nuclear targeting and 
membrane transport.
HIV-2 ROD Vpx is not a shuttling protein
Recent studies have identified HIV-1 Vpr as a shuttling 
protein (Sherman et al. 2001). While the role of nuclear ex-
port of Vpr has not been elucidated, it has been demon-
strated that shuttling is not required for packaging of Vpr, 
but may be important for Vpr-mediated cell-cycle arrest 
(Jenkins et al. 2001). Given the homology between Vpr and 
Vpx, we therefore examined whether Vpx was a shuttling 
protein. To determine whether Vpx shuttled, we used a 
heterokaryon shuttling assay developed by (Jenkins et al. 
2001). In this assay, HeLa cells transiently transfected with 
GFP fusion proteins were plated onto mouse L cells and 
treated with polyethylene glycol (PEG) to initiate cell fu-
sion. Cells were washed and incubated for an additional 
3 h in the presence of cycloheximide. Cells were fixed and 
permeabilized, and nuclei were stained with DAPI. DAPI 
staining of L cells results in nuclei with bright, punctate, 
foci that are easily distinguishable from the HeLa cell nu-
clei ( Figure 6, right panel, denoted with arrows). Shut-
tling can be observed under a fluorescence microscope by 
the movement of the GFP fusion protein to the L cell nu-
clei. For our studies, a GFP–HIV-1 Vpr fusion protein was 
Figure 3. β-gal–Vpx fusions containing Vpx aa 65 to 72 localize 
primarily to the nucleus of transfected cells. 293T cells tran-
siently transfected with the indicated expression vectors were 
fractionated and the β-gal activity was determined for the cy-
toplasmic and nuclear fractions. Separation of the cytoplasmic 
and nuclear fractions was monitored by detection of the cyto-
plasmic LDH protein in the nuclear fraction using a commer-
cially available kit (Sigma). Results are expressed as the ratio of 
nuclear to cytoplasmic (N/C) activity of the β-gal–Vpx fusion 
proteins. Error bars denote the standard error of the mean. 
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used as a positive control, which was observed in the L 
cell nuclei (Figure 6). GFP-HIV-2 Vpx, however, did not 
move into the L cell nuclei when tested, indicating that 
shuttling did not occur. Transient transfection of GFP-
HIV-2 Vpx into L cells alone produced a nuclear pheno-
type, confirming that the absence of GFP-HIV-2 Vpx in 
the L cell nuclei in the fusion assays was due to an ab-
sence of nuclear export from the HeLa cell nuclei and not 
a failure of nuclear import into L cells (data not shown). 
We also assessed whether a GFP–HIV-2 Vpr fusion pro-
tein could shuttle ( Figure 6). Similar to HIV-1 Vpr, the 
GFP–HIV-2 Vpr protein was able to translocate from the 
HeLa nuclei to the L cell nuclei. The lack of shuttling of 
Vpx is consistent with the hypothesis that the shuttling of 
HIV-1 and HIV-2 Vpr is not required for virion incorpo-
ration or PIC import, but rather may be important for an-
other function of Vpr, such as cell-cycle arrest.
Discussion
Nuclear localization of HIV-2 Vpx is necessary for the 
import of the viral preintegration complex into the nu-
cleus of nondividing cells (Fletcher et al. 1996 and Pan-
cio et al. 2000). Studies by Mahalingham et al.. had iden-
tified an NLS within aa 60–85 of Vpx and demonstrated 
that several residues within this region were critical for 
Vpx nuclear localization and virus replication in nondi-
Figure 4. Alanine substitution of critical residues abolishes GFP–Vpx nuclear localization. Epifluorescence images of HeLa cells 
transiently transfected with GFP–Vpx fusion proteins containing the indicated alanine substitutions. After fixation, cells were per-
meabilized and nuclei were stained with DAPI (right panels). 
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viding cells (Mahalingam et al. 2001). The current studies 
have extended this work and identified a minimal trans-
ferable nuclear localization signal of HIV-2 Vpx to aa 65–
72 (…SYTKYRYL…). This stretch of amino acids is highly 
conserved among HIV-2/SIV strains, further suggestive 
of the importance of this region. Classical NLSs are com-
monly either monopartite or bipartite. Monopartite NLSs 
are characterized by a single stretch of three or more ba-
sic residues, whereas bipartite NLSs are composed of two 
stretches of basic residues separated by approximately 
10 amino acids. The Vpx NLS has two basic residues (K68 
and R70) and several tyrosines, but lacks a run of basic 
residues homologous to the classical monopartite NLS. 
Similarly, analysis of the surrounding amino acids failed 
to identify a motif consistent with a bipartite NLS. How-
ever, alanine substitution of K68 and R70 abolished nuclear 
localization of GFP-Vpx, demonstrating that the basic res-
idues are critical components of the Vpx NLS. Therefore, 
given the absence of either a classical monopartite or bi-
partite NLS, it is likely that Vpx may require novel pro-
tein–protein interactions to move across the nuclear pore.
Although previous studies (Mahalingam et al. 2001 
and Pancio et al. 2000) have demonstrated that mutations 
C-terminal to the NLS are deleterious to Vpx nuclear lo-
calization, we were able to map an NLS to a 10-aa region. 
However, the functional β-gal fractionation data would 
suggest that only full-length Vpx maintains complete nu-
clear import capability. There are several possibilities to 
explain this discrepancy. The most obvious explanation 
is that the mutations/deletions that have been previously 
reported may alter Vpx structure such that the NLS is 
compromised and no longer completely functional. A sec-
ond possibility is that the C-terminal mutations disrupt 
another function of Vpx required for full nuclear import 
capability. Further studies would be needed to character-
ize the C-terminus of Vpx and identify any novel func-
tional domains that affect the nuclear transport of Vpx. A 
third theory to explain this discrepancy could be the pres-
ence of a second NLS, such as demonstrated for HIV-1 
Vpr (Jenkins et al. 1998). However, we feel that the broad 
panel of β-gal–Vpx fusions we tested would have likely 
identified a second NLS, if present. Finally, it could also 
be possible that β-gal may have compensated for a do-
main in Vpx to facilitate nuclear import. β-Gal may have 
provided a domain in trans to enhance a weak NLS in the 
smaller fusion proteins. Alternatively, since β-gal exists as 
a tetramer in vivo, the protein could have enhanced nu-
clear targeting of the smaller fusions by multiplying the 
effect of a single, weak NLS. Therefore, a tetramer of fu-
sion proteins containing four weak NLSs would appear to
Figure 5. Membrane targeting of GFP–Vpx alanine mutants. 
U87 cells were infected/transfected as described under Ma-
terials and methods with the indicated GFP–Vpx expression 
plasmids with or without the GagPol expression plasmid 
pTM-GP2. Sixteen hours later cells were fixed and mounted, 
and images were obtained. Membrane localization is denoted 
by arrows. 
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have stronger karyophilic properties. Nevertheless, while 
a larger domain of Vpx may be necessary for full func-
tion, our results demonstrate that aa 65–72 are residues 
critical for the karyophilic properties of HIV-2 Vpx.
In the presence of Gag, Vpx is trafficked to the plasma 
membrane via an interaction with p6 (Selig et al. 1999). 
Previous work demonstrated that mutation of aa 74–86 of 
Vpx reduced Vpx incorporation into virus-like particles 
and aa 80–86 were important for Vpx–Gag interactions (Jin 
et al. 2001). Consistent with these findings, alanine substi-
tution of aa 74–80 or 80–86 abolished membrane transport 
of GFP-Vpx fusions. The alanine substitution of K68 and 
R70 abolished nuclear localization of GFP- Vpx, but had 
no effect on Vpx membrane transport, demonstrating that 
the nuclear localization and membrane transport func-
tions are separable within Vpx. Alanine substitution of aa 
74–80, however, was deleterious to both nuclear localiza-
tion and membrane transport, indicating that these func-
tional domains are not discrete. These findings support a 
model of Vpx transport whereby the interaction of Vpx 
with the p6 region of Gag suppresses the NLS of Vpx to 
target Vpx to the plasma membrane of cells for incorpora-
tion into virions.
The functions of HIV-1 Vpr are shared between HIV-
2 Vpr and Vpx. Both proteins are packaged into viri-
ons and associate with the reverse transcription complex 
early after infection of cells (Fletcher et al. 1996); however, 
only Vpx is thought to play a role in PIC nuclear import 
(Fletcher et al. 1996). Recently, HIV-1 Vpr was identified 
as a shuttling protein (Sherman et al. 2001). Although the 
Figure 6. HIV-2 Vpx does not shuttle. HeLa cells were transiently transfected with the indicated GFP fusion plasmids 18 h prior to 
being plated onto L cells. After allowing the HeLa cells to settle, the cells were fused with PEG, washed, and incubated an addi-
tional 3 h in the presence of cycloheximide. Cells were fixed, permeabilized, and stained with DAPI (right panels). L cells stained 
with DAPI (denoted with arrows) exhibit a bright, punctate staining in comparison to HeLa cells. Shuttling is demonstrated by 
the movement of the GFP fusion protein into the L cell nuclei. 
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functional significance of HIV-1 Vpr shuttling is not clear, 
it has been demonstrated that HIV-1 Vpr shuttling is not 
necessary for packaging into virions (Jenkins et al. 2001). 
Our studies indicated that HIV-2 Vpr, but not Vpx, is a 
shuttling protein. The inability of HIV-2 Vpx to shuttle is 
consistent with the idea that shuttling is not necessary for 
the packaging of Vpr/Vpx proteins (Jenkins et al. 2001). 
Furthermore, the inability of Vpx to shuttle suggests that 
shuttling plays no role in the nuclear import of the HIV-
2 PIC. Rather, since HIV-2 Vpr shuttles, it would seem 
likely that shuttling is important for Vpr-mediated G2 
cell-cycle arrest or another undefined function.
We have identified a minimal NLS of HIV-2 Vpx; how-
ever, questions still remain to define the exact role of Vpx 
in PIC nuclear import. The lack of a “classical” NLS sug-
gests that Vpx may use a novel pathway to access the nu-
clei of cells. Future studies to identify cellular proteins 
that interact with Vpx will further define the pathway 
through which Vpx accesses the nucleus and the role the 
Vpx protein plays as a component of the HIV-2 PIC. De-
lineation of the role the Vpx/Vpr proteins play in the nu-
clear import of the PIC may lead to the development of 
novel therapeutic interventions of HIV infection.
Materials and methods
Plasmid construction
Plasmids pTM-GP2 and pEGFPVpx have been previ-
ously described (Horton et al. 1994 and Pancio et al. 2000). 
To construct lacZ fusions, the lacZ ORF was PCR am-
plified from pCH110 (Amersham Biosciences, Piscat-
away, NJ) using Redi-Taq as described by the manufac-
turer (Sigma-Aldrich, St. Louis, MO). Primer sequences 
are available upon request. The 3′ primer in the reaction 
contained an artificial XhoI restriction site inserted im-
mediately 5′ of the stop codon. The PCR product was TA 
cloned into pcDNA3.1/V5-His-TOPO as described by the 
manufacturer (Invitrogen, Carlsbad, CA). Positive clones 
(pclacZ(XhoI)) were identified by restriction mapping 
and sequencing the 5′ and 3′ insert junctions. All vpx in-
serts for fusion vectors were cloned into the XhoI site of 
the plasmid. For full-length and larger segments of vpx, 
regions were PCR amplified with HIV-2 ROD-specific 
PCR primers containing XhoI sites on both 5′ and 3′ prim-
ers, with premature stop codons in the 3′ primers of trun-
cated fragments. For regions of 12 aa or less, overlapping 
primers were synthesized (IDT Technologies, Iowa City, 
IA), annealed, phosphorylated, and ligated into digested 
pclacZ(XhoI). All clones were confirmed by sequence 
analysis. Alanine substitutions were inserted into pEGFP-
Vpx by Excite Mutagenesis (Stratagene, La Jolla, CA) as 
described by the manufacturer using primers with site-
specific substitutions. Alanine substitutions were con-
firmed by sequence analysis.
Fractionation assays
293T cells were maintained in Dulbecco’s modified Eagle’s 
medium supplemented with 10% fetal calf serum and pen-
icillin/streptomycin. Cells were transfected using TransIT-
LT1 reagent with 2–4 μg of indicated lacZ-fusion plasmids 
as described by the manufacturer (PanVera, Madison, WI). 
Forty-eight hours posttransfection, cells were harvested by 
treatment with PBS + 5 mM EDTA and transferred to 1.5 
mL microcentrifuge tubes. Nuclear and cytoplasmic frac-
tions were obtained using a commercially available kit 
(Pierce Chemical Co., Rockford, IL). Separation of the frac-
tions was confirmed by lack of detectable LDH enzyme 
in the nuclear fractions using a commercially available kit 
(Sigma-Aldrich). Protein concentrations of each fraction 
were determined using a commercially available kit (Pierce 
Chemical Co.). The enzymatic activity of the β-gal fusion 
was determined using a colorimetric microtiter plate assay. 
Results are presented as a ratio of the nuclear to cytoplas-
mic β-gal activity. The results for each fusion represent at 
least three independent experiments, with three separate 
transfections per experiment.
Immunofluorescence analysis
HeLa cells (5 × 105) seeded onto glass coverslips were 
transfected with 2 μg of lacZ fusion expression plasmids 
as described above and incubated overnight. Cells were 
washed, fixed with 4% paraformaldehyde in PBS, washed 
again, and then permeabilized with 0.2% Triton X-100 in 
PBS for 5 min. β-Gal was detected using a monoclonal an-
tibody (Promega), followed by a FITC-conjugated anti-
mouse IgG secondary antibody (Sigma). After the anti-
body incubations, the cells were incubated for 5 min with 
2 μg/mL DAPI to allow for visualization of nuclei. Cells 
were visualized and images obtained using a fluorescence 
microscope equipped with an Optronics Magnafire imag-
ing system (Optronics, Goleta, CA). Multiple images were 
obtained from at least two independent transfections and 
images presented in figures are representative of the dom-
inant phenotype observed.
GFP-Vpx mutant localization and membrane transport assays
U87 cells maintained in DMEM supplemented with 15% 
FBS and penicillin/streptomycin were plated onto glass 
coverslips in six-well plates. For localization assays, HeLa 
cells were transfected with 2 μg of indicated expression 
plasmid as described above. For membrane transport as-
says, U87 cells were infected with VPT7-3 vaccinia virus 
for 1 h in OptiMEM (Invitrogen) and then transfected in 
normal media with 2 μg of indicated GFP-Vpx mutant 
or 1 μg GFP-Vpx mutant, and 1 μg pTM-GP2. U87 cells 
were grown overnight, fixed with 4% paraformaldehyde 
in PBS, washed 3× in PBS + 1% FBS, and mounted onto 
slides. For localization studies, HeLa cells were permea-
bilized with 0.2% Triton X-100 for 5 min after fixation and 
washed, and nuclei were stained with 2 μg/mL DAPI and 
washed again prior to mounting. Slides were visualized 
and multiple images obtained as described above. Images 
presented in figures are representative of the dominant 
phenotype for each mutant.
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Heterokaryon shuttling assays
HeLa and L cells were maintained as described above. 
HeLa cells (5 × 105) were seeded into one well of a six-
well plate and the next day were transfected with 2 μg of 
GFP-fusion plasmid. That same day, L cells were seeded 
onto coverslips in six-well plates at a density of 5 × 105 
cells/well. The next day, the HeLa cells were trypsin-
ized and plated onto the L cells. After allowing the HeLa 
cells to settle (3–5 h), the coverslips were removed and in-
verted onto 50% w/v PEG (Sigma-Aldrich) for 2 min to 
initiate cell–cell fusion. The cells were then washed with 
PBS and incubated for an additional 2 h in media contain-
ing 50 μg/mL cycloheximide. Cells were fixed, permeabi-
lized, stained with DAPI, and mounted, and images were 
obtained as described above.
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